BC Platforms and NTT Group Announce Official Opening Ceremony for Exclusive Collaboration and Launch of Japanese Precision Medicine Platform
Zurich, Switzerland – 15 April 2024 – BC Platforms (BCP), a global leader in real world data, healthcare data management, and analytics, today announces an exclusive collaboration with NTT Life Science Corporation, a company in the medical field of the NTT Group, to accelerate data-driven medicine. Last week, in Japan, an official opening ceremony of a joint Tokyo facility was held, housed within NTT Life Science, which will drive and develop the Japan Precision Medicine PlatformTM (JPP). This marked the concrete beginning of the global partnership. The JPP has the power, for the first time in Japan to enable the usage of clinical data, ensuring the safe and efficient access, sharing and analysis of this data across the nation. JPP is a national medical data distribution platform to integrate, curate, and harmonize Japanese healthcare data enabled by BCP’s technology integrated with NTT’s global network and technology.